Lovastatin Protects against Experimental Plague in Mice
Saravanan Ayyadurai, Hubert Lepidi, Claude Nappez et al. · 2010
Read Lovastatin Protects against Experimental Plague in Mice by Saravanan Ayyadurai, Hubert Lepidi, Claude Nappez et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010928.txt.
Description
Saravanan Ayyadurai, Hubert Lepidi, Claude Nappez and co-authors published this plague study in PLOS ONE in 2010. Plague, caused by the bacterium Yersinia pestis, still kills people yearly in parts of Africa and is classed as a bioterrorism threat. Standard preventive antibiotics face resistant strains, so the team looked for a backup in an unlikely place: a cholesterol drug.
Lovastatin, already known to ease the symptoms of severe infection, was given to mice daily for six days before they were challenged with plague bacteria. Treated and untreated control groups let the authors judge whether pre-treatment changed survival and disease course. Ayyadurai and colleagues test the idea that a cheap, widely available statin could serve as extra protection after exposure. A positive result would matter most where resistant plague strains appear.
Catalog record
| CREATOR | Saravanan Ayyadurai, Hubert Lepidi, Claude Nappez et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010928